Instead, they seem built to help startups, med spas, wellness brands, and developing beauty businesses move from idea to product in a way that feels structured, compliant, and commercially realistic
Melanoma can appear on normal skin tissue and does not always start as a mole
Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes
Injected DSIP has been shown to improve locomotor function, psychological parameters, and reduced lethality of stroke
Other Popular Peptides in the Gray Zone: Thymosin Alpha-1 Immune support (approved in 35+ countries, NOT in US) GHK-Cu (Copper Peptide) Skin/hair (injectable form banned by FDA) Epitalon Claimed anti-aging (no human studies) LL-37 Antimicrobial (research only) AOD-9604 Fat loss (FDA banned) Semorelin Growth hormone release Melanotan II Tanning (serious side effects) The FDA Crackdown: What Happened in Late 2023 Timeline of the Ban: 2023: FDA adds 12+ peptides to "Category 2 Bulk Drug Substances" list What this means: Compounding pharmacies CANNOT legally make these peptides FDA cites "significant safety risks" No approved use in humans Peptides specifically banned from compounding: BPC-157 TB-500 (Thymosin Beta-4 fragment) Thymosin Alpha-1 CJC-1295 Ipamorelin AOD-9604 GHK-Cu (injectable) Epitalon LL-37 DSIP KPV Selank Semax And more
